From the Editor-in-Chief
More basic research is needed to understand how various alterations in genes lead to cancers.
by William G. Nelson, MD, PhD
Editor's Letter
How can Vice President Joe Biden's "Moonshot" initiative make true progress against cancer?
by Kevin McLaughlin
Forward Look
Putting the Immune System in Overdrive | Weighty Matters | A Blood Test for Cancer | Melanoma Risk Increased in Some Lymphoma Survivors | Aspirin Recommended to Reduce Colorectal Cancer Risk | Fine-Tuning Treatments for Triple-Negative Breast Cancer | Don't Get Burned
Your Cancer Guide
Complementary and alternative medicine (CAM) can supplement, but not replace, established cancer treatments.
by Hester Hill Schnipper
Caregiving With Confidence
Follow these tips for keeping your sense of self despite a shift in responsibilities.
by Carly O'Brien
Practical Pointers
Make the most of email, text messages, Twitter and patient portals.
by Ide Mills
Pain is no gain for patients during or after cancer treatment.
by Sue Rochman
Survivor Profile
A metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
Studies focused on individuals rather than large numbers of people can help some patients while advancing knowledge.
by Stephen Ornes
High-deductible health insurance plans can leave cancer patients scrambling to pay the bills for tests and treatments.
by Charlotte Huff
Healthy Habits
What's The Beef? | Less Stress
Q&A
Cancer exercise specialist and survivor Julie Goodale offers tips for staying active during and after treatment.
by Ronni Gordon
Sound Advice
When a family member wants to stop treatment, addressing post-treatment anxiety and sadness, and considering a clinical trial.
Get Involved!
Give patients and their families a break from cancer.
by Maria Wolf
Colleen Bokor, Dana Stewart, Brittany Avin.
Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.
by Anna Azvolinsky
The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.
A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data.
by Marci A. Landsmann
Cancer patients in the U.S. are feeling impacts from the new coronavirus.
by Kate Yandell
Screening reduces lung cancer mortality but is underutilized.
The Food and Drug Administration has approved a combination of two immunotherapy drugs to treat certain patients with liver cancer.
Cancer patients have a unique risk profile in this pandemic.
Handle With Care
donate to the AACR